| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0014 | 1 |